BRAEBON Launches New Gold Standard in Compliance Measurement, Test. Treat. Trac.

Share Article

BRAEBON Medical Corporation announced today that it has made available in North America its DentiTrac® system for oral appliance compliance measurement.

Accurate oral appliance compliance measurement is needed to level the playing field with traditional sleep apnea treatment called CPAP.

The DentiTrac® system has been developed by BRAEBON during the past few years. It is a micro-recorder and web portal combination which defines the new gold standard for measurement of oral appliance wearing time for the treatment of sleep apnea. DentiTrac® is an integrated personal micro-recorder embedded inside an oral appliance to reliably and accurately gather detailed information to assess when a patient is wearing the appliance. The information is then uploaded through a base station to the BRAEBON cloud portal where dental and medical specialists can conveniently and securely review their patient information and assess sleep apnea therapy adherence.

“We are very pleased DentiTrac® is launching in the US and Canadian markets. Accurate oral appliance compliance measurement is needed to level the playing field with traditional sleep apnea treatment called CPAP. In addition, the ability to reliably measure sleep apnea treatment adherence is a vital requirement for insurance payers. We anticipate this will contribute to significant overall growth in the burgeoning field of dental sleep medicine and the use of oral appliance therapy for sleep apnea. The DentiTrac® is the final realization of our Test Treat Trac strategy which empowers clinicians across multiple disciplines to efficiently and collaboratively work together to more effectively manage the sleep apnea patient,” said Dr. Richard Bonato, CEO and Co-Founder.

“The challenge was to develop a measurement technology which could not be easily deceived. This was vital because new US Federal DOT legislation will impact everyone in the transportation industry including all truck drivers, pilots, bus drivers, etc. We had to invent a novel and powerful solution which we’ve secured with IP patent protection. The level of product sophistication connected with our cloud portal is beyond anything we’ve done before. I’m very proud of what our team has accomplished,” said Donald Bradley, CTO and Co-Founder.

BRAEBON has an agreement in place with SomnoMed Limited as the preferred worldwide dorsal fin oral appliance design and for exclusive distribution in the EU and parts of Australasia. In North America BRAEBON is also working with Strong Dental (Leamington, ON), Great Lakes Orthodontics (Tonowanda, NY) and other leading dental laboratories.

About BRAEBON Medical Corporation

BRAEBON is a privately held Canadian corporation and has been in business since 1998 developing and manufacturing medical devices for snoring and sleep apnea in their ISO 13485 manufacturing facility. BRAEBON’s products are sold worldwide for use in the Sleep Medicine and Dental Sleep Medicine fields. BRAEBON is a world leader in portable home sleep apnea testing devices with its MediByte® and MediByte Jr.® recorders as well as its line of sleep sensors and accessories. The Founders of BRAEBON were the original designers of a leading sleep laboratory recording technology which became dominant during the transition from paper to digital recording 20 years ago.

For additional information contact Mr. Mitch Livingston, VP Business Development, by telephone at 613.831.6690 x220, via email at mitchl(at)braebon(dot)com or visit BRAEBON at http://www.braebon.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mitch Livingston
BRAEBON
(613)-831-6690 220
Email >
Visit website